Problem:
Verifying Accurate Leading-edge IVCT Development (VALID) Act is part of the December omnibus spending bill. If VALID doesn’t pass, how will LDTs be regulated to ensure patients are getting accurate results?
Solution:
The FDA could use ‘Rulemaking’ to enforce diagnostic reform. That approach could potentially take years to impact patient care. Read on to learn more!
The nonprofit Center for Genomic Interpretation (CGI) can assist by taking a non-biased approach by reviewing testing options to ensure the tests are being accurately represented. When choosing a genetic testing lab, ensure you are ordering or choosing a lab for ‘in network’ status that is delivering accurate results! Let us analyze this quickly and inexpensively today! Our review of a lab test’s technical accuracy costs less than a single risk reducing surgery or precision medicine therapy option.
Please email truth-in-genomics@genomicinterpretation.org to sign up for monthly newsletters and follow Center For Genomic Interpretation on LinkedIn to keep up with this ever changing industry!
View newsletter HERE!
The post December 2022 – The Data Driven Point of View appeared first on Center for Genomic Interpretation.
Problem: Verifying Accurate Leading-edge IVCT Development (VALID) Act is part of the December omnibus spending bill. If VALID doesn’t pass, how will LDTs be regulated to ensure patients are getting accurate results? Solution: The FDA could use ‘Rulemaking’ to enforce diagnostic reform. That approach could potentially take years to impact patient care. Read on to learn more!
The post December 2022 – The Data Driven Point of View appeared first on Center for Genomic Interpretation.